Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production

COVID-19 vaccines
Specialty vaccine company Valneva’s inactivated COVID-19 jab has shown positive results in a Phase I/II trial, with a seroconversion rate of 100% in...
Janssen sign
Janssen has struck a deal worth up to $780 million with Cidara Therapeutics for exclusive worldwide rights to Cidara’s CD388 medicine for the...
Pfizer sign
Pfizer and BioNTech’s follow-up study of their COVID-19 vaccine has confirmed the jab’s high efficacy after up to six months, with an effectiveness...
Alnylam Pharmaceuticals, a RNAi therapeutics company, have published successful results from their Phase III study of lumasiran, the first ever...

Features

As NICE approves the most expensive drug ever for use by the NHS, Jack Goddard takes a look at drug pricing in the UK, how it...

Appointments

Intravac have announced the appointment of Nathalie Laarakker as its new CFO and member of the company’s executive management team.

...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches